It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Ferroptosis is a type of iron-dependent regulated cell death, representing an emerging disease-modulatory mechanism. Transcription factors play multiple roles in ferroptosis, although the key regulator for ferroptosis in iron metabolism remains elusive. Using NanoString technology, we identify NUPR1, a stress-inducible transcription factor, as a driver of ferroptosis resistance. Mechanistically, NUPR1-mediated LCN2 expression blocks ferroptotic cell death through diminishing iron accumulation and subsequent oxidative damage. Consequently, LCN2 depletion mimics NUPR1 deficiency with respect to ferroptosis induction, whereas transfection-enforced re-expression of LCN2 restores resistance to ferroptosis in NUPR1-deficient cells. Pharmacological or genetic blockade of the NUPR1-LCN2 pathway (using NUPR1 shRNA, LCN2 shRNA, pancreas-specific Lcn2 conditional knockout mice, or the small molecule ZZW-115) increases the activity of the ferroptosis inducer erastin and worsens pancreatitis, in suitable mouse models. These findings suggest a link between NUPR1-regulated iron metabolism and ferroptosis susceptibility.
Ferroptosis is an iron-dependent form of oxidative cell death. In this study, the authors show that NUPR1, a stress-inducible transcription factor, may be a driver of ferroptosis resistance.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Guangzhou Medical University, The Third Affiliated Hospital, Key Laboratory of Protein Modification and Degradation, Guangdong, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072)
2 UT Southwestern Medical Center, Department of Surgery, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121)
3 University of Pittsburgh, Department of Surgery, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000)
4 Central South University, Department of Oncology, The Second Xiangya Hospital, Changsha, China (GRID:grid.216417.7) (ISNI:0000 0001 0379 7164)
5 Sorbonne Paris Cité, Université Paris Descartes, Paris, France (GRID:grid.469994.f) (ISNI:0000 0004 1788 6194); Centre de Recherche des Cordeliers, Equipe 11 labellisée Ligue Nationale contre le Cancer, Paris, France (GRID:grid.417925.c); Institut National de la Santé et de la Recherche Médicale, Paris, France (GRID:grid.7429.8) (ISNI:0000000121866389); Université Pierre et Marie Curie, Paris, France (GRID:grid.462844.8) (ISNI:0000 0001 2308 1657); Gustave Roussy Cancer Campus, Metabolomics and Cell Biology Platforms, Villejuif, France (GRID:grid.14925.3b) (ISNI:0000 0001 2284 9388); Hôpital Européen Georges Pompidou, AP-HP, Pôle de Biologie, Paris, France (GRID:grid.414093.b); Karolinska University Hospital, Department of Women’s and Children’s Health, Stockholm, Sweden (GRID:grid.24381.3c) (ISNI:0000 0000 9241 5705)
6 Guangzhou Medical University, The Third Affiliated Hospital, Key Laboratory of Protein Modification and Degradation, Guangdong, China (GRID:grid.410737.6) (ISNI:0000 0000 8653 1072); UT Southwestern Medical Center, Department of Surgery, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121)